Gaithersburg, Maryland (MD) Commercial Medical Research Companies
Featured companies
USA Oncology Phase III Clinical Trial - http://clinicaltrials.gov - NCT01064466 - http://clinicaltrials.gov/ct2/show/NCT01064466 -
Not satisfied? Select a reason•Rate this page•Send feedback
Or try our search form or quick navigation by category and location
The Hugh And Carolyn Shelton Military Neurotrauma Foundation
12321 Middlebrook Road
Gaithersburg MD 20877
(301) 428-9818
Whereorg has 5 results under Commercial Medical Research Companies in Gaithersburg, MD.
Other categories for location Montgomery, Maryland
All industries
Professional Services Commercial Physical and Biological Research Commercial Medical Research
Other locations for category Commercial Medical Research
Quick navigation
All industries
Professional Services
Commercial Physical and Biological Research
Commercial Medical Research
Subcategory
- Agricultural Laboratories2
- Biological Research17
- Biotechnology Products and Services2
- Chemical Laboratory, Except Testing1
- Commercial Biotechnical Research20
- Commercial Physical Research4
- Commercial Research Laboratory2
- Electronic Research and Development5
- Energy Research52
- Environmental and Ecological Services52
- Food Analysis1
- Industrial Laboratory, Except Testing1
- Laboratories6
- Research and Development Laboratories101
- Testing1
Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020